<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01635595</url>
  </required_header>
  <id_info>
    <org_study_id>Cardia AdCa UNIBO</org_study_id>
    <nct_id>NCT01635595</nct_id>
  </id_info>
  <brief_title>Nodal Status in Adenocarcinoma of the Esophagus an Cardia</brief_title>
  <official_title>AdCa of the Esophagus and Cardia (ADEC): Relationship Between Nodal Metastasization and the Presence Absence of Intestinal Metaplasia in the Esophagus and Stomach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bologna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adenocarcinoma of the distal esophagus and cardia are grouped among the thoracic tumors
      according to the TNM 7th ed., however controversy is pending on the unique or dual
      pathogenesis (GERD or gastric-like cancerogenesis). It has been shown that biological
      patterns differ according to the presence (+) or absence (-) of Barrett's epithelium (BIM)
      and gastric intestinal metaplasia (GIM) in the fundus and antrum. Lymphatic metastatic
      spreading may differ according to the type of tumor. The investigators retrospectively
      investigated the pathways of lymphatic spreading in 194 consecutive patients who received
      radical surgery for adenocarcinoma of the esophagus and cardia with or without BIM and GIM.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The assumption that adenocarcinoma of the esophagus and cardia (ADEC) originates only from
      the sequence intestinal metaplasia followed by dysplasia and cancer is controversial. It has
      been shown that biological patterns differ according to the presence (+) absence (-) of
      Barrett's epithelium (BIM) and of gastric intestinal metaplasia (GIM) in the fundus and
      antrum. Lymphatic metastatic spreading may differ according to the type of tumor.

      Preoperatively patients underwent histological search for Barrett's esophagus (BIM) in mucosa
      surrounding (ADEC) and intestinal metaplasia in the gastric corpus and antrum mucosa (GIM).
      Patients in which BIM was documented underwent sub total esophagectomy and gastric pull up
      (group 1), others underwent esophagectomy at the azygos vein + total gastrectomy with Roux Y
      esophagojejunostomy (group 2). Radical lymphadenectomy was identical in both procedures
      except for the greater curvature station.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">194</enrollment>
  <condition>Adenocarcinoma of the Esophagus</condition>
  <condition>Adenocarcinoma of the Gastric Cardia</condition>
  <arm_group>
    <arm_group_label>Patients with BIM</arm_group_label>
    <description>Patients affected by adenocarcinoma of the distal esophagus and cardia with preoperative diagnosis of BIM underwent subtotal esophagectomy and gastric pull up.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without BIM</arm_group_label>
    <description>Patients affected by adenocarcinoma of the distal esophagus and cardia without preoperative diagnosis of BIM underwent subtotal esophagectomy at the azygos vein, total gastrectomy and esophagojejunostomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subtotal esophagectomy and gastric pull up</intervention_name>
    <description>Subtotal esophagectomy and gastric pull up and radical thoracic (2,3,4R,7,8,9)and abdominal (15,16,17,18,19,20) lymphadenectomy</description>
    <arm_group_label>Patients with BIM</arm_group_label>
    <other_name>Esophagectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subtotal esophagectomy at the azygos vein, total gastrectomy</intervention_name>
    <description>Subtotal esophagectomy at the azygos vein, total gastrectomy and esophagojejunostomy and radical thoracic (2,3,4R,7,8,9) abdominal (15,16,17,18,19,20) lymphadenectomy.</description>
    <arm_group_label>Patients without BIM</arm_group_label>
    <other_name>Esophagectomy</other_name>
    <other_name>Gastrectomy</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a preoperative diagnosis of adenocarcinoma of the distal esophagus and cardia
        who underwent surgery up to December 2011, which fully adhered to the pre and postoperative
        protocol, including endoscopic gastric mucosa sampling.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preoperative diagnosis of adenocarcinoma of the distal esophagus and cardia

          -  preoperative from local to locally advanced disease

          -  absence of neoadjuvant therapy

        Exclusion Criteria:

          -  neoadjuvant therapy

          -  metastatic disease

          -  unfit for surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandro Mattioli, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bologna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Thoracic Surgery, Center for the Study and Therapy of Diseases of the Esophagus. Alma Mater Studiorum - University of Bologna, GVM Care &amp; Research, Maria Cecilia Hospital</name>
      <address>
        <city>Cotignola</city>
        <state>Ravenna</state>
        <zip>48010</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Mattioli S, Di Simone MP, Ferruzzi L, D'Ovidio F, Pilotti V, Carella R, D'Errico A, Grigioni WF. Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus. 2001;14(2):104-9.</citation>
    <PMID>11553218</PMID>
  </reference>
  <results_reference>
    <citation>Mattioli S, Ruffato A, Di Simone MP, Corti B, D'Errico A, Lugaresi ML, Mattioli B, D'Ovidio F. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors. Ann Thorac Surg. 2007 May;83(5):1814-9.</citation>
    <PMID>17462405</PMID>
  </results_reference>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2012</study_first_submitted>
  <study_first_submitted_qc>July 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2012</study_first_posted>
  <last_update_submitted>July 24, 2012</last_update_submitted>
  <last_update_submitted_qc>July 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bologna</investigator_affiliation>
    <investigator_full_name>Sandro Mattioli</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

